Advertisement
Advertisement

The Internet Journal of Hematology ISSN: 1540-2649


Assessment of the knowledge of thalassemia in the thalassemia patients and the treatment received by them


Jagriti Upadhyay MBBS Christian Medical College
Saurav Chatterjee MBBS, ECFMG certified Resident, Neurology Intensive Therapy Unit, National Neurosciences Centre, Peerless Hospital

Citation:  J. Upadhyay & S. Chatterjee: Assessment of the knowledge of thalassemia in the thalassemia patients and the treatment received by them. The Internet Journal of Hematology. 2009 Volume 5 Number 2


Abstract

An analytical study was done on 20 thalassemic patients to asses their knowledge about their disease and treatment recommended for it. Individual interviews were conducted on the basis of a prepared questionnaire which were analysed. The study revealed lack of knowledge of the patients about their disease and treatment available and recommended for thalassemia. The study also showed that patients were not receiving the ideal treatment due to lack of knowledge and financial constraints. Appropriate health education was conducted to create awareness about thalassemia and its treatment among the patients. This study sensitized us to the need for improving the knowledge of the patients about their health condition and their management.


Objectives

To assess the knowledge of the thalassemic patients about their disease and the treatment received by them.

Subjects

Age group-5 to 30 years suffering from Thalassemia.

Design

Individual interviews were conducted with 20 patients using a pre-prepared questionnaire.

Hemoglobin level and spleen size on the day of the transfusion was recorded.

The data collected was tabulated and analysed.

70% of the children were <80% of their ideal weight and were malnourished.

7 out of 20 were either lagging behind their peers of same age or had discontinued studies due to the disease.

Table 5 Surprisingly only 2 out of 20 children were born of consanguinous marriage.

Disease was diagnosed in 80% by the age of 3.

21 % felt that the disease was infectious.2 even related it to DPT and polio vaccines.

2 attributed it to liver disease.

7 out of 20 patients believed that the disease is curable.

16 out of 20 patients had some knowledge of the types of thalassemia though only 8 knew about the severity of the disease.

50% of patients held the opinion that consanguinity has no role to play in thalassemia.

7 had some family history of thalassemia. One child’s mother had thalassemia and died during the delivery.

8 people who were not tested was due to :

Fear of being diagnosed positive.

Cost

Didn’t understand the importance.

Father abandoned the family when child was diagnosed thalassemia.

Desferral is very famous. About half of them had no idea about other options for chelation.

12 out of 20 have not heard of BMT which is probably good considering the economic background they have.

5 of them had not done Hb:

Duoe to cost

They feel they know when the child needs transfusion “bhalo lagche na”.” we give it every month”.

For most of the children chelation was started quite late than the ideal and fe deposition was quite evident due to the blackening of the skin.

Only 3 were getting chelation the ideal no. times

Reasons-cost, knowledge,

long distance travel.

Outcomes

1) 70% of the children were <80% of their ideal weight and were malnourished.

2) 7 out of 20 were either lagging behind their peers of same age or had discontinued studies due to the disease.

3) Disease was diagnosed in 80% by the age of 3.

4) 16 out of 20 patients had some knowledge of the types of thalassemia though only 8 knew about the severity of the disease.

5) 50% of patients held the opinion that consanguinity has no role to play

6) Reasons for the parents of 8 patients who were not tested for thalassemia included

Fear of being diagnosed positive.

Cost

Didn’t understand the importance.

Father abandoned the family when child was diagnosed thalassemia.

7) Desferroxamine was popular. About half of them had no idea about other options for chelation.

8) 12 out of 20 had not heard of bone marrow transplant.

9) 5 of them had not done Hb on the day of transfusion due to cost. 5 of them had not done Hb:

10) For most of the children chelation was started quite late than the ideal time and iron deposition was quite evident due to the blackening of the skin

11) Only 3 were getting chelation the ideal no. times

12) Only 2 out of 6 patients who had undergone splenectomy , had received vaccine prophylaxis.

Measures

Appropriate health education was conducted to create awareness among the people on thalassemia and its treatment.

Conclusion

This study sensitized us to the need for improving the knowledge of the patients about their health condition which will help in improving their management.

Annexure

Questionnaire to Assess the knowledge of thalassemia in the thalassemia patients and the treatment received by them

Date of interview:

Name: Address:

Age: Contact No.

Sex: I P Reg No.

Education: Informant:

Weight:

Consanguineous marriage

Knowledge about Thalassemia

When was the disease diagnosed (at what age)?

What type of a disease is it? (contagious/infectious/genetic/cancer/blood disorder/others)

Is it curable?

Do you know that there are different types of thalassemia? if yes what are the types and their severity?

Do you know that consanguinity has a role in thalassemia?

Do any of the siblings have thalassemia?

Any family history of thalassemia?

Have parents been tested for thalassemia?

What is the role of chelation in thalassemia? What are the options for chelation available that you know of?

How many times are you supposed to get chelation in a month?

Do you know about splenectomy and why is it done?

Do you know the option of BMT?

Do you know the types of food to avoid?

Treatment received by the patient:

What is the hemoglobin level when they are getting transfusion?

(I recorded the Hb on the day of transfusion)

Are you getting packed cell or whole blood?

How many transfusions are you getting per year?

How many transfusions have you got so far?

When was the chelation therapy started(after how many transfusions/transfusion rate/year at that time)

How many times per month are you getting desferral?

If its less than ideal(15-20) what is the reason(cost/lack of knowledge)

Has the patient undergone splenectomy?

When?indication?

Vaccine prophylaxis given?

Have you received Hepatitis B vaccine?

Is the patient on penicillin prophylaxis after splenectomy?

References

1. Black, M. B., Miller, H. and Wan, J.. Quantitative determination of haemoglobin A2 by filter paper electrophoresis. Tech. Bull. Registry & Med. Techn., 36: 221-223, 1966.
2. Dacie, J. V. and Lewis, S. M.: "Practical Hematology". English, Language Book Society and Churchill Livingstone, London, 1975, p. 202.
3. Hammond, D., Sturgeon, P., Bergren, W. and Caviles, A.: Definition of Cooley's trait or thalassemia minor; Classical, clinical and laboratory hematology. Ann. New York Acad. Sci., 119: 372-389, 1964.
4. Mehta, B. C., Agarwal, M. B., Kurlekar, N. and Varandani, D. G.: Diagnostic criteria of beta thalassemia trait. Study of 171 parents of patients with Cooley's anemia (In Press).
5. Singer, K., Chernoff, A. Z. and Singer, L. Studies on abnormal hemoglobin; their demonstration in sickle cell anemia and other hematology disorders by means of alkali denaturation. Blood: 6: 413-428, 1951.
6. Weatherall, D. J. and Clegg, J. E.: "The Thalassemia Syndrome". 2nd Edition, Blackwell Scientific Publications, Oxford, 1972, p. 109.

Generated at: Fri, 10 Feb 2012 01:32:43 -0600 (0000011f) — http://www.ispub.com:80/journal/the-internet-journal-of-hematology/volume-5-number-2/assessment-of-the-knowledge-of-thalassemia-in-the-thalassemia-patients-and-the-treatment-received-by-them.html